Latest news


PCI Biotech: Update on the preclinical research collaboration agreement with AstraZeneca

Posted on Jul 14, 2020

Oslo (Norway), 13 July 2020 – PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, today announced a 6 month extension of the evaluation period under its preclinical research collaboration with AstraZeneca. The collaboration was initiated in September 2015 to determine whether PCI Biotech’s fimaNAc technology has the potential to enhance the delivery of AstraZeneca’s […]

Minutes from Annual General Meeting 2020

Posted on May 27, 2020

Oslo, 27 May 2020. The Annual General Meeting in PCI Biotech Holding ASA took place today, 27 May 2020. All proposals were resolved by the Annual General Meeting as presented in the notice convening the general meeting distributed on 6 May 2020. The complete minutes of the Annual General Meeting are attached to this release […]

Disclosure of voting rights for Chairman of the Board

Posted on May 26, 2020

Oslo, 26 May 2020. PCI Biotech Holding ASA (“PCI Biotech” or the “Company”) issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual general meeting of the Company on 27 May 2020. Mr. Bøhn holds 123,662 shares, representing 0.3 per cent […]